Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Klorhex Plus is a dual-action pharmaceutical formulation designed for the treatment of oral and pharyngeal conditions. It combines the antimicrobial properties of chlorhexidine digluconate with the anti-inflammatory and analgesic effects of flurbiprofen, a non-steroidal anti-inflammatory drug (NSAID). This synergistic action targets both infectious and inflammatory components of conditions such as gingivitis, stomatitis, pharyngitis, tonsillitis, aphthous lesions, and mucositis, as well as for post-dental procedure management and dental plaque prevention. It is manufactured by Drogsan Pharmaceuticals and is available as an oral spray and gargle solution for topical application.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Klorhex Plus.